Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers
Authors:
- Patrizia GarbatiPGPatrizia Garbati
- Cristiana PiccoCPCristiana Picco
- Raffaella MagrassiRMRaffaella Magrassi
- Paolo SignorelloPSPaolo Signorello
- Ludovica CacopardoLudovica Cacopardo
- Mauro Dalla SerraMSMauro Dalla Serra
- Maria Grazia FaticatoMFMaria Grazia Faticato
- Maria De LucaMLMaria De Luca
- Francesco BalestraFBFrancesco Balestra
- Maria Principia ScavoMaria Principia Scavo
- Federica VitiFVFederica Viti
Open Access
- 21 March 2024
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (3) , 431
Abstract
The intestine is essential for the modulation of nutrient absorption and the removal of waste. Gut pathologies, such as cancer, inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and celiac disease, which extensively impact gut functions, are thus critical for human health. Targeted drug delivery is essential to tackle these diseases, improve therapy efficacy, and minimize side effects. Recent strategies have taken advantage of both active and passive nanocarriers, which are designed to protect the drug until it reaches the correct delivery site and to modulate drug release via the use of different physical–chemical strategies. In this systematic review, we present a literature overview of the different nanocarriers used for drug delivery in a set of chronic intestinal pathologies, highlighting the rationale behind the controlled release of intestinal therapies. The overall aim is to provide the reader with useful information on the current approaches for gut targeting in novel therapeutic strategies.Keywords
Funding Information
- Fondazione Telethon (GSA22Q001, GSA22B001)
This publication has 354 references indexed in Scilit:
- pH‐Triggered Release and Degradation Mechanism of Layered Double Hydroxides with High Loading CapacityAdvanced Materials Interfaces, 2023
- Probiotic‐Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut MicrobiomeAdvanced Materials, 2022
- Microfluidized Dextran Microgels Loaded with Cisplatin/SPION Lipid Nanotherapeutics for Local Colon Cancer Treatment via Oral AdministrationAdvanced Healthcare Materials, 2022
- Rapid Surface Display of mRNA Antigens by Bacteria‐Derived Outer Membrane Vesicles for a Personalized Tumor VaccineAdvanced Materials, 2022
- Heparin‐Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed IntestineAdvanced Healthcare Materials, 2020
- Highly Biocompatible Functionalized Layer‐by‐Layer Ginger Lipid Nano Vectors Targeting P‐Selectin for Delivery of Doxorubicin to Treat Colon CancerAdvanced Therapeutics, 2019
- Cell Membrane Coating NanotechnologyAdvanced Materials, 2018
- Nanocarrier‐Integrated Microspheres: Nanogel Tectonic Engineering for Advanced Drug‐Delivery SystemsAdvanced Materials, 2015
- Biocompatible, Uniform, and Redispersible Mesoporous Silica Nanoparticles for Cancer‐Targeted Drug Delivery In VivoAdvanced Functional Materials, 2013
- Modified katira gum for colon targeted drug deliveryJournal of Applied Polymer Science, 2010